Cargando…
Kanglemycin A Can Overcome Rifamycin Resistance Caused by ADP-Ribosylation by Arr Protein
Rifamycins, such as rifampicin (Rif), are potent inhibitors of bacterial RNA polymerase (RNAP) and are widely used antibiotics. Rifamycin resistance is usually associated with mutations in RNAP that preclude rifamycin binding. However, some bacteria have a type of ADP-ribosyl transferases, Arr, whic...
Autores principales: | Harbottle, John, Mosaei, Hamed, Allenby, Nicholas, Zenkin, Nikolay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597724/ https://www.ncbi.nlm.nih.gov/pubmed/34606341 http://dx.doi.org/10.1128/AAC.00864-21 |
Ejemplares similares
-
Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021) -
Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance
por: Lan, Tian, et al.
Publicado: (2022) -
Mode of Action of Kanglemycin A, an Ansamycin Natural Product that Is Active against Rifampicin-Resistant Mycobacterium tuberculosis
por: Mosaei, Hamed, et al.
Publicado: (2018) -
Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycins
por: Ganapathy, Uday S., et al.
Publicado: (2023) -
Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism
por: Peek, James, et al.
Publicado: (2018)